Detalhe da pesquisa
1.
Development of MDS-Based Predication Model for COPD Severity in Nursing Home Residents.
Ann Pharmacother
; 56(8): 878-887, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34963317
2.
Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data.
Curr Ther Res Clin Exp
; 94: 100629, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34306269
3.
Associations between seizure severity change and patient characteristics, changes in seizure frequency, and health-related quality of life in patients with focal seizures treated with adjunctive eslicarbazepine acetate: Post hoc analyses of clinical trial results.
Epilepsy Behav
; 112: 107312, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801102
4.
The Lifetime Burden of Schizophrenia as Estimated by a Government-Centric Fiscal Analytic Framework.
J Clin Psychiatry
; 84(5)2023 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37555674
5.
Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam in the long-term care setting in the USA.
J Comp Eff Res
; 11(17): 1293-1308, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331060
6.
Point-in-time survey of healthcare resource utilization, employment, quality of life and caregiver status by disease severity in patients with schizophrenia in the US.
Curr Med Res Opin
; 38(3): 469-478, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34812100
7.
The incidence and economic burden of extrapyramidal symptoms in patients with schizophrenia treated with second generation antipsychotics in a Medicaid population.
J Med Econ
; 25(1): 87-98, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34913797
8.
Healthcare resource utilization and quality of life by cognitive impairment in patients with schizophrenia.
Schizophr Res Cogn
; 28: 100233, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35004189
9.
Burden of EPS in commercial patients with schizophrenia initiating atypical antipsychotics.
Am J Manag Care
; 28(9): e315-e324, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36121363
10.
The Economic Burden of Schizophrenia in the United States.
J Clin Psychiatry
; 83(6)2022 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36244006
11.
Indirect comparison of apomorphine sublingual film and levodopa inhalation powder for Parkinson's disease 'OFF' episodes.
J Comp Eff Res
; 11(4): 285-295, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35068168
12.
Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study.
J Med Econ
; 24(1): 1212-1220, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647502
13.
Cost-Effectiveness of Apomorphine Sublingual Film as an "On-Demand" Treatment for "OFF" Episodes in Patients with Parkinson's Disease.
J Health Econ Outcomes Res
; 8(2): 82-92, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35178465
14.
Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs.
Clinicoecon Outcomes Res
; 13: 251-261, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33907433
15.
Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis.
Neurol Ther
; 10(2): 673-691, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826104
16.
Healthcare resource utilization, costs and treatment patterns in patients with bipolar disorder treated with lurasidone or cariprazine.
J Med Econ
; 24(1): 352-362, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588674
17.
Hospitalization risk among adults with bipolar I disorder treated with lurasidone versus other oral atypical antipsychotics: a retrospective analysis of Medicaid claims data.
Curr Med Res Opin
; 37(5): 839-846, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682547
18.
Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD.
J Med Econ
; 24(1): 939-948, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34311671
19.
Healthcare Resource Utilization Pre- and Post-Initiation of Eslicarbazepine Acetate Among Pediatric Patients with Focal Seizure: Evidence from Routine Clinical Practice.
Clinicoecon Outcomes Res
; 12: 379-387, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801808
20.
Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses.
Neurol Ther
; 9(2): 585-598, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949379